Skip to content
Grand Gamble Pro

Individuals Coming Off Weight-Loss Jabs Regain Weight Four Times Faster Compared to Dieters

Image of pharmaceutical syringe and scale
Obesity treatment involves long-term strategies.

New research indicates that patients who discontinue popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight at a significantly accelerated pace than those who end traditional diet and exercise programs.

Published data in a prominent medical journal demonstrates that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.

"People buying such medications should be aware of the risk of rapid rebound weight gain when the therapy is stopped," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a return to original mass in about a year and a half.

Comparing Approaches

The research, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with conventional dieting.

Researchers point out that people who lose weight through diet and exercise generally experience a less rapid weight regain—approximately 100 grams monthly—once they finish.

The Reason for the Quick Regain

Experts propose the mechanism of the injections explains the amplified regain.

The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.

"Artificially providing the hormone levels several times higher than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this hormone supplement means hunger is unsuppressed, making overeating much more probable."

A Chronic Condition?

The NHS suggest the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Professionals say that, due to the significant potential of weight regain, the treatment might need to be long-term.

This view is reinforced by drug manufacturers, who note that the findings "emphasize the chronic nature of obesity," similar to managing conditions like high blood pressure.

User Accounts

Individuals who have discontinued the medication explain a powerful return of cravings.

"It was like a switch activating and you're instantly ravenous," described one woman.

This difficulty is worsened if users have not adopted lasting lifestyle or habit changes during treatment.

Growing Use

Figures show that a significant number of adults in the UK have used these injections in the past year, with interest continuing to grow.

  • Use is higher among females compared to males.
  • The middle-aged age group shows the highest usage rates.
  • Many obtain the medications through private healthcare rather than the NHS.

Ultimately, experts emphasize that while the jabs are powerful tools for weight loss, they are not a permanent fix and maintained weight loss likely depends on integrated lifestyle changes.

Written by

Phyllis Snyder

A seasoned gambling analyst with over a decade of experience in sports betting and casino strategy, specializing in data-driven insights.

Grand Gamble Pro

Type to search articles.